Such a role for NKp46 was previously suggested when Arnon et al. showed by IHC that primary human prostate tumors and not benign prostate hyperplasia expressed ligands for NKp46 and NKp30 [36]. The gene discussed is NCR3; the disease is prostate neoplasm.